December 2017

Scotland: A HepatoPancreatoBiliary Cancers education event was held at Perth Royal Infirmary on Friday, 15 December. The programme included Streamlining MDTs – IHDP and the HPB MCN, Neuroendocrine Tumours and HPB 2016 Audit Analysis.

The Scottish Cancer Networks Collaborative Oesophago-gastric Cancer Event was held on 27 October 2017 in Forth Valley Royal Hospital organised by the West of Scotland Cancer Network. Information Services Division (ISD) carried out survival analysis on UGI cancer data collected across Scotland for 2016.  The preliminary results of this analysis were presented and appeared to show survival differences across the three regions.  It was agreed that further indepth analysis should be carried out and a meeting has been arranged in January to define the scope of the further analysis required.  It was agreed that attendees should comprise of UGI Clinical Leads, Network Managers, Information Managers from the 3 Regional Cancer Networks and representatives from ISD.

Graeme Couper (Scotland rep)

August 2017

Scotland: The AUGIS 2018 ASM will take place in Edinburgh – look our for further details soon! There will be a Scottish Upper GI National Meeting 2017 taking place at the Learning, Education & Training Centre at the Forth Valley Royal Hospital on Friday, October 27.

February 2017

Scotland: The Scottish Cancer Networks for Oesophagogastric and Hepatopancreaticobiliary cancer held separate meetings in November. The HPB meeting at the Aberdeen Royal Infirmary included analysis of the surgical audit for 2015. It was well-attended meeting and included presentations on the management of pancreatic lesions and trial updates among other topics.

The oesophagogastric meeting at Perth Royal Infirmary was attended by all interested specialities and included a review of the Quality Performance Indicators for 2015. External opinion was provided by Professor Bill Allum from the Royal Marsden. As in previous years, issues highlighted included the lack of resource for dietetics and regional variations in curative treatments offered to oesophageal cancer patients. The issue of positive CRM in patients undergoing oesophagectomy is to be reviewed across the regions. The QPI reports for the two specialities are available on the Scottish Cancer Network website.